AAPG

At a glance

Ascentage Pharma Group International (AAPG) is listed on NASDAQ and classified in Biotechnology, part of the Healthcare sector. It is headquartered in Suzhou, China and has 828 employees. The company is worth $1.44B. Revenue was CN¥574.12M in fiscal 2025, down 41.5% from the year before. It reported a net loss of CN¥1.24B. The share price is 57.1% below its 52-week high of $35.86. One of the 38 superinvestors we track held it at the end of Q2 2026: Steve Cohen (Point72 Asset Management), at $243.05K. No open-market insider trades in it were filed over the last 30 days.

Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.

Key metrics

Market cap

$1.44B

P/E

—

Forward P/E

—

P/B

17.2x

Dividend yield

0.00%

Payout

—

EPS

-$2.26

ROE

-236.63%

Profit margin

-228.54%

Revenue growth

+29.30%

Beta

0.66

52-week high

$35.86

52-week low

$14.46

History

Year by year, from the annual reports; dividends from the payments themselves.

Revenue, debt and profit are in CNY, the currency the company reports in — not converted to dollars. Dividends are in dollars.

Investors holding this

Major managers that reported this stock in their latest 13F.

• SC
  Steve CohenHeld

  Point72 Asset Management · Q2 2026
  $243.05K

  13.84K shares · 0.0% of portfolio

Others in the same sector

Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.

About the company